Maximum number of tokens in answers: 705
Average number of tokens in answers: 65.19484053553936
Evaluation Model Used: gpt-5
Number of Prompts Printed: 5
Number of Prompts Used for Calculating the Average for Each Metric: 20 

================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
Undernutrition in neonates increases the risk of serious morbidities. The objective of this study was to describe neonatal morbidity associated with low body fat percentage (BF%) and measure the number of undernourished neonates defined by BF% and compare this with birth weight percentiles (<10th). Eligibility included term (≥37 wk) neonates. BF% measurements were undertaken by air displacement plethysmography. Data on neonatal outcomes were extracted from medical records and used to develop a measure of neonatal morbidity. We assessed the association between neonatal morbidity and population-based birth weight percentiles compared with the BF% measurements. Five hundred and eighty-one neonates were included. Low BF% was defined by 1 SD below the mean and identified in 73 per 1,000 live births. Neonatal morbidity was found in 3.4% of neonates. Birth weight percentile was associated with neonatal morbidity (odds ratio (OR): 1.03 (95% confidence interval (CI): 1.01, 1.05); P =<0.001). BF% was associated with a higher risk of neonatal morbidity (OR: 1.30 (95% CI: 1.15, 1.47); P =<0.001).
Question:
Is body fat percentage a better measure of undernutrition in newborns than birth weight percentiles?
[/INST]

Generated Answer: Yes, body fat percentage (BF%) is a better measure of undernutrition in newborns than birth weight percentiles. The study found that low BF% was associated with a higher risk of neonatal morbidity, and this association was independent of birth weight percentile. This suggests that BF% may be a more accurate measure of undernutrition in newborns than birth weight percentiles.

The study found that 73 per 1,000 live births had low BF%, which was defined as 1 SD below the mean. This is a significant proportion of newborns, highlighting the importance of assessing undernutrition beyond birth weight. Birth weight percentiles are a crude measure of undernutrition, as they do not take into account the distribution of body fat in newborns.

In contrast, BF% is a more direct measure of body fatness, and it has been shown to be a better predictor of morbidity and mortality in newborns than birth weight percentiles. The study found that BF% was associated with a higher risk of neonatal morbidity, even after adjusting for birth weight percentile.

Overall, the study suggests that BF% may be a better measure of undernutrition in newborns than birth weight percentiles. This is because BF% provides a more direct measure of body fatness, which is a critical indicator of nutritional status in newborns.

Provided Answer: In this population, measuring BF% is more closely associated with identification of neonates at risk of neonatal morbidity as compared with birth weight percentiles. BF% measurements could assist with identifying neonates who are appropriately grown yet undernourished and exclude small neonates not at risk. 

correctness: 0.6
Reasoning:
The answer correctly concludes that BF% is a better measure than birth weight percentiles for identifying undernutrition risk, which aligns with the study’s finding that BF% is more strongly associated with neonatal morbidity. However, it introduces unsupported claims: it asserts independence/adjustment relative to birth weight percentiles and extends the conclusion to mortality, neither of which are stated in the provided context. These overstatements reduce accuracy.

conciseness: 0.4
Reasoning:
The response clearly answers "Yes" and explains that BF% better identifies morbidity risk. However, it is not concise: it repeats the main point, includes extraneous details (e.g., specific prevalence, claims about independence/adjustment and mortality not in the prompt), and could be summarized in one or two sentences.

relevance: 0.7
Reasoning:
The response is relevant and answers the question by stating that BF% is a better measure than birth weight percentiles, aligning with the context showing a stronger association between BF% and neonatal morbidity. It correctly references specific context details (e.g., 73 per 1,000 low BF%). However, it adds unsupported claims about independence/adjustment and mortality, which are not stated in the provided context.

coherence: 0.9
Reasoning:
The response directly answers the yes/no question with a clear "Yes" and provides a structured rationale linking BF% to neonatal morbidity. It cites relevant figures from the context (e.g., low BF% prevalence) and contrasts BF% with birth weight percentiles. While it includes some assertions not explicitly stated in the prompt (e.g., independence from/adjustment for birth weight, mortality), these do not disrupt coherence. Overall, the answer is organized and logically consistent with the question.

helpfulness: 0.7
Reasoning:
The response directly answers the question with a clear “yes” and cites the study’s key finding that BF% is more strongly associated with neonatal morbidity than birth weight percentiles, which aligns with the provided context. It also mentions the prevalence of low BF% (73/1,000), adding relevance.

However, it overreaches by claiming the association was independent of and adjusted for birth weight percentile—this is not stated in the provided context. It also extends the claim to mortality, which the study did not address. Additionally, it misses the useful nuance that BF% can identify appropriately grown yet undernourished neonates and exclude small neonates not at risk.

Overall, helpful and mostly aligned, but with some overstatements and missed nuance.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
We retrospectively collected and analyzed data of all diabetic patients affected by Charcot neuroarthropathy in combination with critical limb ischemia, which arrived to our care for the presence of foot lesions and underwent endovascular revascularization, followed by surgical and orthopedic treatment between January 2010 and January 2012. The primary end point was to assess the limb salvage rate. The secondary end point was to evaluate the healing time of the lesions. Ten diabetic patients (10 men; mean age 69.1±8.5 years), affected by ischemic Charcot neuroarthropathy underwent endovascular revascularization, surgical debridement and orthopedic correction. The limb salvage rate was 90%, avoiding major amputation in 9 patients. In one patient (10%) the infection could not be controlled and below-the-knee amputation was carried out. The required time to heal the lesion was in mean 197.4±22.4 days, after revascularization, surgical and orthopedic treatment.
Question:
Ischemic Charcot foot: different disease with different treatment?
[/INST]

Generated Answer: Yes, ischemic Charcot foot is a distinct condition from Charcot neuroarthropathy, and it requires different treatment approaches. While Charcot neuroarthropathy is a neurological disorder that affects the feet and can lead to foot deformities and ulcerations, ischemic Charcot foot is caused by a reduction in blood flow to the foot, which can lead to tissue damage and infection.

The primary end point of treating ischemic Charcot foot is to restore blood flow to the affected area, which can be achieved through endovascular revascularization, surgical debridement, and orthopedic correction. The goal of these interventions is to prevent or delay the progression of the disease and reduce the risk of major amputation.

In contrast, the primary end point of treating Charcot neuroarthropathy is to manage the neurological symptoms and prevent further deformity and ulceration. This may involve a combination of non-surgical and surgical interventions, such as physical therapy, orthotics, and surgical correction of deformities.

In summary, while both conditions are related to diabetes and foot complications, ischemic Charcot foot requires a different treatment approach than Charcot neuroarthropathy, with a focus on restoring blood flow and preventing further tissue damage.

Provided Answer: Patients with Charcot foot deformity can be affected by critical limb ischemia and revascularization therapy is necessary, to support surgical and orthopedic treatment, avoiding amputation and leading to limb and foot salvage. 

correctness: 0.4
Reasoning:
The answer correctly emphasizes the need for revascularization alongside surgical and orthopedic management to avoid major amputation, aligning with the study’s finding that restoring blood flow is key. However, it mischaracterizes “ischemic Charcot foot” as a distinct disease separate from Charcot neuroarthropathy rather than Charcot complicated by critical limb ischemia, which is the core point. It also omits the key outcomes (90% limb salvage; ~197 days to heal) and inaccurately frames Charcot management as primarily addressing “neurological symptoms” rather than offloading and deformity control.

conciseness: 0.6
Reasoning:
The response conveys the core idea that ischemic Charcot foot requires a different approach with revascularization to reduce amputation risk, aligning with the ground truth. However, it is not concise: it includes background distinctions and broader management details that go beyond the essential point and omits a succinct, direct statement that revascularization is necessary to support surgical/orthopedic treatment for limb salvage.

relevance: 0.3
Reasoning:
The response is partially relevant: it conveys that ischemic Charcot foot requires a treatment strategy centered on revascularization alongside surgical/orthopedic care to avoid amputation, which aligns with the context. However, it does not reference or quote any specific statements from the provided context (e.g., the 90% limb salvage rate or the necessity of revascularization to support surgery/orthopedics), and it incorrectly reframes the study’s “primary end point” as restoring blood flow rather than limb salvage. Therefore, it lacks the required direct linkage to a real quote from the context.

coherence: 0.9
Reasoning:
The response is coherent and well-structured. It directly addresses the question by stating that ischemic Charcot foot is managed differently, then contrasts ischemic Charcot foot (emphasizing revascularization and limb salvage) with typical Charcot neuroarthropathy management. It follows a logical flow with a clear conclusion and aligns with the provided context about revascularization and limb salvage. Minor redundancy is present, but overall the answer remains organized and coherent.

helpfulness: 0.8
Reasoning:
The answer directly addresses the question, clearly stating that ischemic Charcot foot requires a different treatment approach focused on restoring blood flow, aligning with the context and ground truth emphasizing revascularization alongside surgical and orthopedic care to avoid amputation. It helpfully contrasts this with standard Charcot neuroarthropathy management. However, it slightly overstates “distinct condition” rather than Charcot complicated by ischemia, and it misses referencing the study’s supportive outcomes (90% limb salvage, ~197 days to heal), which would strengthen the response.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
Radical hysterectomy is recommended for endometrial adenocarcinoma patients with suspected gross cervical involvement. However, the efficacy of operative procedure has not been confirmed. The patients with endometrial adenocarcinoma who had suspected gross cervical involvement and underwent hysterectomy between 1995 and 2009 at seven institutions were retrospectively analysed (Gynecologic Oncology Trial and Investigation Consortium of North Kanto: GOTIC-005). Primary endpoint was overall survival, and secondary endpoints were progression-free survival and adverse effects. A total of 300 patients who underwent primary surgery were identified: 74 cases with radical hysterectomy (RH), 112 patients with modified radical hysterectomy (mRH), and 114 cases with simple hysterectomy (SH). Median age was 47 years, and median duration of follow-up was 47 months. There were no significant differences of age, performance status, body mass index, stage distribution, and adjuvant therapy among three groups. Multi-regression analysis revealed that age, grade, peritoneal cytology status, and lymph node involvement were identified as prognostic factors for OS; however, type of hysterectomy was not selected as independent prognostic factor for local recurrence-free survival, PFS, and OS. Additionally, patients treated with RH had longer operative time, higher rates of blood transfusion and severe urinary tract dysfunction.
Question:
Surgery for endometrial cancers with suspected cervical involvement: is radical hysterectomy needed (a GOTIC study)?
[/INST]

Generated Answer: Yes, according to the GOTIC-005 study, radical hysterectomy is recommended for endometrial adenocarcinoma patients with suspected gross cervical involvement. The study found that patients who underwent radical hysterectomy had a longer overall survival compared to those who underwent modified radical hysterectomy or simple hysterectomy. However, the study did not find a significant difference in local recurrence-free survival, progression-free survival, or overall survival between the three groups.

The study included 300 patients who underwent primary surgery for endometrial adenocarcinoma with suspected gross cervical involvement at seven institutions between 1995 and 2009. The patients were retrospectively analyzed, and the primary endpoint was overall survival. Secondary endpoints included progression-free survival and adverse effects.

The results of the study showed that the median age of the patients was 47 years, and the median duration of follow-up was 47 months. There were no significant differences in age, performance status, body mass index, stage distribution, and adjuvant therapy among the three groups. Multi-regression analysis revealed that age, grade, peritoneal cytology status, and lymph node involvement were identified as prognostic factors for overall survival. However, type of hysterectomy was not selected as an independent prognostic factor for local recurrence-free survival, progression-free survival, or overall survival.

Radical hysterectomy was associated with longer operative time, higher rates of blood transfusion, and severe urinary tract dysfunction compared to modified radical hysterectomy or simple hysterectomy. However, the study did not find any significant differences in the rates of these adverse effects among the three groups.

In conclusion, the GOTIC-005 study suggests that radical hysterectomy is a recommended surgical approach for endometrial adenocarcinoma patients with suspected gross cervical involvement. While the study did not find a significant difference in local recurrence-free survival, progression-free survival, or overall survival among the three groups, radical hysterectomy was associated with longer overall survival. Therefore, radical hysterectomy is the recommended surgical approach for these patients.

Provided Answer: Type of hysterectomy was not identified as a prognostic factor in endometrial cancer patients with suspected gross cervical involvement. Perioperative and late adverse events were more frequent in patients treated with RH. The present study could not find any survival benefit from RH for endometrial cancer patients with suspected gross cervical involvement. Surgical treatment in these patients should be further evaluated in prospective clinical studies. 

correctness: 0.1
Reasoning:
The assistant’s answer misinterprets the study’s findings and is internally inconsistent. The GOTIC-005 study found no survival benefit from radical hysterectomy (RH) versus modified radical or simple hysterectomy; type of hysterectomy was not an independent prognostic factor for OS, PFS, or local control. It also reported more perioperative and late adverse events with RH. The assistant incorrectly claims RH is recommended and associated with longer overall survival, and also contradicts itself by stating both presence and absence of OS differences, and incorrectly states no significant differences in adverse effects. Overall, the response is largely inaccurate relative to the ground truth.

conciseness: 0.2
Reasoning:
The response is not concise. It includes extensive study details (e.g., median age, follow-up) that are unnecessary for answering the yes/no question. It is also repetitive and contains contradictory statements, which further obscures the core takeaway. A concise answer should directly state whether radical hysterectomy is needed and briefly note the lack of survival benefit and higher morbidity.

relevance: 0.2
Reasoning:
The response is not aligned with the context or ground truth. It incorrectly concludes that radical hysterectomy (RH) is recommended and associated with longer overall survival, whereas the study found no survival benefit and did not identify hysterectomy type as a prognostic factor. It also misstates adverse events, claiming no significant differences despite the context noting higher perioperative and urinary complications with RH. While it includes some accurate elements (e.g., multivariate factors), the core conclusion and several details contradict the provided context.

coherence: 0.2
Reasoning:
The response is poorly coherent. While it is structured with an introduction, methods, results, and conclusion, it contains multiple internal contradictions. It first claims radical hysterectomy is recommended and associated with longer overall survival, then states there was no significant difference in survival outcomes among groups. It also contradicts itself regarding adverse events, noting higher complications with radical hysterectomy but later claiming no significant differences in adverse effects. These inconsistencies undermine coherence and clarity.

helpfulness: 0.2
Reasoning:
The response is inconsistent and misrepresents the study’s findings. It incorrectly claims radical hysterectomy (RH) is recommended and associated with longer overall survival, which contradicts the study’s conclusion that hysterectomy type was not a prognostic factor and that there was no survival benefit from RH. It also wrongly states there were no significant differences in adverse events, despite RH having more perioperative and late complications. Although it includes some correct study details (e.g., prognostic factors like age, grade, cytology, nodes), the key takeaway is incorrect and the answer is internally contradictory, reducing its helpfulness.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
The morbidity and mortality of pancreaticoduodenectomy (PD) have significantly decreased over the past decades to the point that they are no longer the sole indicators of quality and safety. In recent times, hospital readmission is increasingly used as a quality metric for surgical performance and has direct implications on health-care costs. We sought to delineate the natural history and predictive factors of readmissions after PD. The clinicopathologic and long-term follow-up data of 1,173 consecutive patients who underwent PD between August 2002 and August 2012 at the Massachusetts General Hospital were reviewed. The NSQIP database was linked with our clinical database to supplement perioperative data. Readmissions unrelated to the index admission were omitted. We identified 173 (15 %) patients who required readmission after PD within the study period. The readmission rate was higher in the second half of the decade when compared to the first half (18.6 vs 12.3 %, p = 0.003), despite a stable 7-day median length of stay. Readmitted patients were analyzed against those without readmissions after PD. The demographics and tumor pathology of both groups did not differ significantly. In the multivariate logistic regression analysis, pancreatic fistula (18.5 vs 11.3 %, OR 1.86, p = 0.004), multivisceral resection at time of PD (3.5 vs 0.6 %, OR 4.02, p = 0.02), length of initial hospital stay>7 days (59.5 vs 42.5 %, OR 1.57, p = 0.01), and ICU admissions (11.6 vs 3.4 %, OR 2.90, p = 0.0005) were independently associated with readmissions. There were no postoperative biochemical variables that were predictive of readmissions. Fifty percent (n = 87) of the readmissions occurred within 7 days from initial operative discharge. The reasons for immediate (≤7 days) and nonimmediate (>7 days) readmissions differed; ileus, delayed gastric emptying, and pneumonia were more common in early readmissions, whereas wound infection, failure to thrive, and intra-abdominal hemorrhage were associated with late readmissions. The incidences of readmissions due to pancreatic fistulas and intra-abdominal abscesses were equally distributed between both time frames. The frequency of readmission after PD is 15 % and has been on the uptrend over the last decade.
Question:
Understanding hospital readmissions after pancreaticoduodenectomy: can we prevent them?
[/INST]

Generated Answer: Yes, there are several strategies that can help prevent hospital readmissions after pancreaticoduodenectomy (PD). Here are some of the key findings from the study that may be relevant to prevention:

1. Pancreatic fistula: The study found that pancreatic fistula was a significant predictor of readmission after PD, with a odds ratio (OR) of 1.86. This suggests that preventing or effectively managing pancreatic fistula may help reduce readmissions.
2. Multivisceral resection at time of PD: The study found that patients who underwent multivisceral resection at the time of PD were at higher risk of readmission, with an OR of 4.02. This suggests that avoiding multivisceral resection whenever possible may help reduce readmissions.
3. Length of initial hospital stay >7 days: The study found that patients who had a longer initial hospital stay were at higher risk of readmission, with an OR of 1.57. This suggests that optimizing the length of initial hospital stay may help reduce readmissions.
4. ICU admissions: The study found that patients who were admitted to the intensive care unit (ICU) were at higher risk of readmission, with an OR of 2.90. This suggests that avoiding ICU admission whenever possible may help reduce readmissions.
5. Postoperative biochemical variables: The study found that none of the postoperative biochemical variables were predictive of readmissions. This suggests that monitoring and managing postoperative biochemical variables may not be a key strategy for preventing readmissions after PD.

Based on these findings, some potential strategies for preventing readmissions after PD may include:

1. Improving pancreatic fistula management: This may involve using better techniques for fistula repair, such as using staplers or sutures, or using adjunctive therapies like topical pancreatic enzyme therapy.
2. Optimizing surgical techniques: This may involve avoiding multivisceral resection whenever possible, and using techniques that reduce the risk of pancreatic fistula.
3. Streamlining postoperative care: This may involve optimizing the length of initial hospital stay, and reducing the need for ICU admission.
4. Improving patient education: This may involve educating patients and their families about the signs and symptoms of readmission, and providing them with resources to manage postoperative care.
5. Developing new technologies: This may involve developing new technologies, such as bioengineered pancreatic tissue, that can reduce the risk of pancreatic fistula and other complications after PD.

It is important to note that these strategies are based on the findings of the study and may not be applicable to all patients undergoing PD. Further research is needed to confirm these findings and to identify additional strategies for preventing readmissions after PD.

Provided Answer: The complexity of initial resection and pancreatic fistula were independently associated with hospital readmissions after PD. Further efforts should be centered on preventing early readmissions, which constitute half of all readmissions. 

correctness: 0.4
Reasoning:
The response correctly identifies key predictors of readmission after PD (pancreatic fistula, multivisceral resection, longer initial stay, ICU admission) and notes that postoperative biochemical variables were not predictive, aligning with the study. However, it misses a central conclusion: that half of readmissions occur within 7 days and efforts should focus on preventing early readmissions. It also proposes speculative or inappropriate prevention strategies (e.g., “topical pancreatic enzyme therapy,” avoiding ICU admission, bioengineered tissue), which are not supported by the study and could be misleading. Overall, while some facts are accurate, the prevention recommendations are weak and partially incorrect.

conciseness: 0.3
Reasoning:
The response is overly long and includes speculative, unsupported prevention ideas (e.g., bioengineered tissue) rather than focusing concisely on the core findings. It fails to highlight the key takeaways that complexity of the initial resection and pancreatic fistula independently predict readmission and that efforts should prioritize preventing early readmissions, which comprise half of cases. Thus, it is not concise or tightly aligned with the provided answer.

relevance: 0.6
Reasoning:
The response is largely relevant: it answers the question using specific findings from the provided context (e.g., citing pancreatic fistula OR 1.86 and multivisceral resection OR 4.02 as predictors, and noting length of stay >7 days and ICU admission). However, it omits the key takeaway that half of readmissions occur within 7 days and that efforts should focus on preventing early readmissions. It also introduces speculative prevention strategies (e.g., topical pancreatic enzyme therapy, bioengineered tissue) not supported by the context.

coherence: 0.7
Reasoning:
The response is generally coherent and well-structured: it summarizes key predictive factors from the study and proposes prevention strategies in a logical bullet-point format. However, it makes some speculative leaps (e.g., “topical pancreatic enzyme therapy,” “bioengineered pancreatic tissue”) and infers prevention tactics from associations (e.g., “avoid ICU admission,” “optimize length of stay”) without clear rationale, which slightly undermines coherence. It also omits the important emphasis on early readmissions and their distinct causes, which would have sharpened the prevention focus.

helpfulness: 0.4
Reasoning:
The answer partially addresses prevention by highlighting predictors (pancreatic fistula, multivisceral resection) and suggesting general strategies. However, it misses the key takeaway that efforts should focus on preventing early readmissions, which constitute half of all readmissions. It also proposes questionable or impractical measures (e.g., “avoiding ICU admission,” optimizing length of stay based on association, speculative technologies like bioengineered tissue) and implies that non-predictive labs are not worth monitoring, which is not a sound preventive approach. Overall, it is only moderately helpful and lacks focus on the most actionable insight from the study.

================================================================================
Average correctness Score: 0.545
Average conciseness Score: 0.525
Average relevance Score: 0.6
Average coherence Score: 0.69
Average helpfulness Score: 0.565
